Awardee OrganizationDIVISION OF BASIC SCIENCES - NCI
Description
Abstract Text
Transcription of major histocompatibility complex (MHC) class I genes is regulated by both tissue-specific (basal) and hormone/cytokine (activated) mechanisms. Although promoter-proximal regulatory elements have been characterized extensively, the roles of the core promoter and downstream elements in mediating regulation have been largely undefined. Basal and activated transcriptions of an MHC class I gene target distinct core promoter domains, nucleate distinct transcription initiation complexes and initiate at distinct sites within the promoter. Basal and activated transcription pathways recruit distinct transcription factor complexes to the core promoter elements and target distinct transcription initiation sites. Basal transcription is completely dependent upon the general transcription factor TAF1 whereas activated transcription is TAF1 independent. To further characterize regulation of class I gene expression, we have undertaken to characterize core promoter elements in vivo and to identify novel downstream promoter elements. To understand these mechanisms in more detail, we have characterized elements within the core promoter of the MHC class I gene. The minimal class I core promoter has been localized to a segment between -50 bp and +14 bp. Within this segment are sequences similar to canonical TATA and Inr promoter elements and an Sp1 binding site; however, no single element is necessary for transcription, although each provides some level of regulation in different cell types. For instance, the Inr element is a negative regulator in fibroblasts, but a positive regulator in T and B cell lines. Conversely, the TATA-like element is a positive regulator in T cell lines, but a negative regulator in B cell and fibroblast lines. Importantly, the roles of these core promoter elements has been examined and verified in vivo in transgenic mice bearing MHC class I genes mutated in the relevant promoter elements. Of particular interest, the downstream region of the MHC class I promoter region, between +1 and +32 bp, contains two novel regulatory elements. Under constitutive conditions, the two elements act in concert to down-regulate promoter activity, preferentially suppressing the use of TSS located at the 5 end of the cluster of multiple start sites. These elements repress constitutive, TAF1-dependent transcription. However, under activated TAF1-independent conditions, one element functions independently as an enhancer. Thus, the downstream regulatory elements associated with the class I promoter function to fine-tune and integrate both intracellular and extracellular signaling pathways to ensure the appropriate level of MHC class I transcription to maintain immune homeostasis. These novel downstream elements are functionally and mechanistically distinct from previously described downstream elements in mammalian promoters. Importantly, we have now identified a second promoter element within the core promoter region. This novel promoter element alone is capable of supporting transcription of a reporter gene in the presence or a heterologous enhancer. Furthermore, it is capable of supporting CIITA-activated transcription of a reporter gene. Most significantly, this novel promoter drives the expression of the native MHC class I gene both in stably transfected L cells and in transgenic mice. Thus, this promoter element, like the first, is capable of supporting both constitutive and activated transcription in vitro and in vivo. The roles of the two distinct promoters in regulating MHC class I transcription is an active area of investigation. Finally, novel regulatory elements that serve to establish tissue specific patterns of regulation have been identified by in vivo analysis and localized to intronic regions.
No Sub Projects information available for 1ZIABC009279-24
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1ZIABC009279-24
Patents
No Patents information available for 1ZIABC009279-24
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1ZIABC009279-24
Clinical Studies
No Clinical Studies information available for 1ZIABC009279-24
News and More
Related News Releases
No news release information available for 1ZIABC009279-24
History
No Historical information available for 1ZIABC009279-24
Similar Projects
No Similar Projects information available for 1ZIABC009279-24